Aromatase inhibitors—hormonal therapy drugs commonly used in the treatment of postmenopausal breast cancer—may increase the risk of heart disease. These results were presented at the 2010 San Antonio Breast Cancer Symposium. Tamoxifen and aromatase inhibitors are hormonal therapy drugs that …
Source: Breast Cancer News